These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23960727)

  • 21. [G-CSF treatment in a case of Kostmann's infantile congenital neutropenia].
    Pastor Gómez AM; Estella Aguado J; Toll Costa T; Mateo Moraja M; Romera Modamio G; Alcorta Loyola I
    An Esp Pediatr; 1998 Jan; 48(1):68-70. PubMed ID: 9542230
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant myeloid transformation in a child with severe congenital neutropenia (Kostmann's syndrome).
    Chong LA; Josephine P; Ariffin H
    Med J Malaysia; 2006 Jun; 61(2):236-8. PubMed ID: 16898320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor use in neutropenic patients infected with human immunodeficiency virus.
    Ambati BK; Perlman DC; Salomon N
    Int J Infect Dis; 1998-1999 Winter; 3(2):70-5. PubMed ID: 10225983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.
    Nichols CR; Fox EP; Roth BJ; Williams SD; Loehrer PJ; Einhorn LH
    J Clin Oncol; 1994 Jun; 12(6):1245-50. PubMed ID: 7515413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).
    Klein C
    J Clin Immunol; 2017 Feb; 37(2):117-122. PubMed ID: 27943080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with chronic benign granulocytopenia and congenital agranulocytosis (Kostmann's syndrome).
    Imashuku S; Tsuchida M; Sasaki M; Shimokawa T; Nakamura H; Matsuyama T; Taniguchi N; Oda M; Higuchi S; Ishimoto K
    Acta Paediatr; 1992 Feb; 81(2):133-6. PubMed ID: 1381248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
    El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
    Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration.
    Imashuku S; Hibi S; Kataoka-Morimoto Y; Yoshihara T; Ikushima S; Morioka Y; Todo S
    Br J Haematol; 1995 Jan; 89(1):188-90. PubMed ID: 7530477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
    Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.
    Lydaki E; Bolonaki E; Stiakaki E; Dimitriou H; Kalmantis T; Kalmanti M
    Pediatr Hematol Oncol; 1995; 12(6):551-8. PubMed ID: 8589000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of effects of KRN8601 (rhG-CSF) on neutropenia].
    Nakahata T; Akabane T; Miura A; Tada K; Uzuka Y; Hayashi T; Shibata A; Shiko S; Okuni M; Urabe A
    Rinsho Ketsueki; 1992 Feb; 33(2):123-32. PubMed ID: 1378911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low doses of colony-stimulating factors lead to resolution of neutropenia in cancer patients through increased levels of dihydrofolate reductase.
    Iqbal MP; Burney IA
    Pak J Pharm Sci; 2014 Mar; 27(2):245-8. PubMed ID: 24577909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenteric vasculitis after G-CSF administration in a severe neutropenic patient with systemic lupus erythematosus.
    Kim YG; Kim SR; Hwang SH; Jung JY; Kim HA; Suh CH
    Lupus; 2016 Oct; 25(12):1381-4. PubMed ID: 27009623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.